Skip to main content
Log in

The role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective: To evaluate the role of non-invasive dynamic tests in the diagnosis and differential diagnosis of Cushing’s syndrome (CS). Methods: We studied laboratory features of 74 patients with endogenous CS, subdivided as follows: 46 (62.1%) with Cushing’s disease (CD), 21 (28.3%) with an adrenal tumor, and 7 (9.5%) with ectopic ACTH syndrome (EAS). Results: In 100% of cases of CS we found serum cortisol levels greater than 1.8 μg/dl after low-dose dexamethasone suppression tests (LDDST), as well as elevation of midnight serum or salivary cortisol. However, urinary free cortisol was normal in 11.5% of patients. ACTH levels were suppressed in patients with adrenal tumors, normal or high in CD and invariably increased in EAS. After the 8-mg overnight dexamethasone suppression test (HDDST), serum cortisol suppression >50% was observed in 79.5% of cases of CD and in 28.6% of subjects with EAS, whereas cortisol suppression >80% was only found in CD. After stimulation with CRH or desmopressin an ACTH rise ≥ 35% occurred in 86.5% of individuals with CD and 14.3% of those with EAS, whereas an ACTH rise ≥ 50 achieved 100% specificity. Moreover, the combination of serum cortisol suppression >50% after HDDST and an ACTH increase ≥ 35% after the administration of CRH or desmopressin only occurred in CD. Conclusion: Our findings demonstrate that LDDST had 100% sensitivity for the diagnosis of CS and that HDDST and stimulation tests with CRH or desmopressin may be very useful for confirmation of CS etiology when analyzed together or when more stringent cutoffs are used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vilar L, Coelho CE. Diagnosis and differential diagnosis of Cushing’s syndrome. In: Vilar L, Kater CE, Naves LA eds. Clinical Endocrinology. 3rd ed. Rio de Janeiro: Guanabara Koogan. 2006, 397–417.

    Google Scholar 

  2. Newell-Price J, Trainer P, Besser GM, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998, 19: 647–72.

    PubMed  CAS  Google Scholar 

  3. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet 2006, 367: 1605–17.

    Article  PubMed  CAS  Google Scholar 

  4. Vilar L, Freitas MC, Faria M, et al. Pitfalls in the diagnosis of Cushing’s syndrome. Arq Bras Endocrinol Metab 2007, 51: 1207–16.

    Article  Google Scholar 

  5. Findling JW, Raff H. Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 2005, 34: 385–402.

    Article  PubMed  Google Scholar 

  6. Lindsay JR, Nieman LK. Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am 2005, 34: 403–22.

    Article  PubMed  CAS  Google Scholar 

  7. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997, 34: 222–9.

    Article  PubMed  CAS  Google Scholar 

  8. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 1995, 43: 545–50.

    Article  CAS  Google Scholar 

  9. Bruno OD, Rossi MA, Contreras LN, et al. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing’s syndrome. Acta Endocrinol (Copenh) 1985, 109: 158–62.

    CAS  Google Scholar 

  10. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 1986, 104: 180–6.

    Article  PubMed  CAS  Google Scholar 

  11. Terzolo M, Reimondo G, Alì A, et al. The limited value of the desmopressin test in the diagnostic approach to Cushing’s syndrome. Clin Endocrinol (Oxf) 2001, 54: 609–16.

    Article  CAS  Google Scholar 

  12. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adreno-corticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1993, 77: 1308–12.

    PubMed  CAS  Google Scholar 

  13. Oldfield EH, Chrousos GP, Schulte HM, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985, 312: 100–3.

    Article  PubMed  CAS  Google Scholar 

  14. Castinetti F, Morange I, Dufour H, et al. Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome. Eur J Endocrinol 2007, 157: 271–7.

    Article  PubMed  CAS  Google Scholar 

  15. Findling JW, Kehoe ME, Shaker JL, Raff H. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorti-cotropin (ACTH)-dependent Cushing’s syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab 1991, 73: 408–13.

    Article  PubMed  CAS  Google Scholar 

  16. Vilar L, Freitas MC, Canadas V, et al. Performance of low-dose dexamethasone suppression tests in obesity and in Cushing’s syndrome. Arq Bras Endocrinol Metab 2002, 46 (Suppl. 1): S493–4.

    Google Scholar 

  17. Findling JW, Raff H. Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 2005, 34: 385–402.

    Article  PubMed  Google Scholar 

  18. Kaye TB, Crapo L The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990, 112: 434–44.

    Article  PubMed  CAS  Google Scholar 

  19. Meier CA, Biller BMK. Clinical and biochemical evaluation of Cushing’s syndrome. Endocrinol Metab Clin N Am 1997, 26: 741–62.

    Article  CAS  Google Scholar 

  20. Mengden T, Hubmann P, Muller J, Greminger P, Vetter W. Urinary free cortisol vs 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing’s syndrome. Clin Invest 1992, 70: 545–8.

    CAS  Google Scholar 

  21. Nieman LK, Cutler GB Jr. The sensitivity of the urine free cortisol measurement as a screening test for Cushing’s syndrome. Program of the 72nd Annual Meeting of the Endocrine Society, Atlanta, GA, 1990, p. 822 (abstract)

    Google Scholar 

  22. Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorti-cotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 2006, 91: 371–7.

    Article  PubMed  CAS  Google Scholar 

  23. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 2005, 90: 4955–62.

    Article  PubMed  CAS  Google Scholar 

  24. Salgado LR, Fragoso MCBV, Knoepfelmacher M, et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol 2006, 155: 725–33.

    Article  PubMed  CAS  Google Scholar 

  25. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1994, 78: 418–22.

    PubMed  CAS  Google Scholar 

  26. Findling JW, Raff H. Cushing’s syndrome: Important issues in diagnosis and management. J Clin Endocrinol Metab 2006, 91: 3746–53.

    Article  PubMed  CAS  Google Scholar 

  27. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999, 84: 440–8.

    PubMed  CAS  Google Scholar 

  28. Loli P, Vignati F, Grossrubatscher E, et al. Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques. J Clin Endocrinol Metab 2003, 88: 1029–35.

    Article  PubMed  CAS  Google Scholar 

  29. Reimondo G, Paccotti P, Minetto M, et al. The corticotrophin-re-leasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing’s syndrome. Clin Endocrinol (Oxf) 2003, 58: 718–24.

    Article  CAS  Google Scholar 

  30. Malerbi DA, Mendonça BB, Liberman B, et al. The desmopressin stimulation test in the differential diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 1993, 38: 463–72.

    Article  CAS  Google Scholar 

  31. Colombo P, Passini E, Re T, Faglia G, Ambrosi B. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clin Endocrinol (Oxf) 1997, 46: 661–8.

    Article  CAS  Google Scholar 

  32. Tsagarakis S, Tsigos C, Vasiliou V, et al. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 2002, 87: 1646–53.

    PubMed  CAS  Google Scholar 

  33. de Keyzer Y, Lenne F, Auzan C, et al. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 1996, 97: 1311–8.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Testa RM, Albiger N, Occhi G, et al. The usefulness of combined biochemical tests in the diagnosis of Cushing’s disease with negative pituitary magnetic resonance imaging. Eur J Endocrinol 2007, 156: 241–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Vilar MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vilar, L., Freitas, M.C., Naves, L.A. et al. The role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome. J Endocrinol Invest 31, 1008–1013 (2008). https://doi.org/10.1007/BF03345640

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345640

Key Words

Navigation